Renalytix
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Renalytix's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 33% to $2,289,000. The net income raised on -$33,456,000 and profit margin reached -1462%. Total operating expenses were $29,041,000.

Profit Margin

Renalytix Plc (NASDAQ:RNLX): Profit margin
2019 0 -5.55M
2020 0 -9.84M
2021 1.49M -31.01M -2079.81%
2022 2.97M -56.73M -1910.17%
2023 3.40M -45.60M -1340.2%
2024 2.28M -33.45M -1461.6%

RNLX Income Statement (2019 – 2024)

2024 2023 2022 2021 2020 2019
Revenue
Revenue
2.28M3.40M2.97M1.49M00
Cost of revenue
2.13M2.70M2.05M804K74K30.99K
Gross profit
156K701K918K687K-74K-30.99K
Operating exp.
Research and development
9.29M14.29M14.64M10.04M4.56M39.59M
Selling and marketing
000000
Total operating expenses
29.04M43.05M58.29M33.29M11.07M6.53M
Operating income
-29.60M-42.35M-57.37M-32.61M-11.07M-6.53M
Other income (expenses), net
-3.84M-3.38M7.74M-3.17M-295K19K
Income before tax
-33.45M-46.22M-49.62M-35.78M-10.61M-6.51M
Income tax expense
4K2K7.10M-4.77M0-959K
Net income
-33.45M-45.60M-56.73M-31.01M-9.84M-5.55M
Earnings per share
Basic EPS
-0.31-0.55-1.56-0.87-0.17-0.26
Diluted EPS
-0.31-0.55-1.56-0.87-0.17-0.26
Data sourceData sourceData sourceData sourceData source